Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Revenue by Segment

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical	53.33B	46.14B	37.78B	31.49B	30.13B
Pharmaceutical Growth	15.59%	22.11%	20.00%	4.51%	26.18%
Nutritional	15.02B	13.78B	11.41B	12.36B	11.94B
Nutritional Growth	8.95%	20.77%	-7.69%	3.58%	39.92%
Diagnostic	5.34B	6.54B	4.77B	4.13B	3.80B
Diagnostic Growth	-18.24%	36.91%	15.53%	8.66%	77.12%
Others	1.70B	1.72B	1.50B	1.27B	1.31B
Others Growth	-0.89%	14.36%	18.06%	-2.83%	80.27%
Total	75.40B	68.18B	55.48B	49.26B	47.18B
Total Growth	10.59%	22.90%	12.62%	4.40%	33.72%

Revenue by Geography

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pakistan	72.75B	65.42B	53.22B	47.20B	40.51B
Pakistan Growth	11.20%	22.91%	12.76%	16.52%	20.85%
Afghanistan	1.55B	1.46B	994.09M	797.45M	1.19B
Afghanistan Growth	6.23%	47.02%	24.66%	-32.97%	6.64%
Sri Lanka	44.26M	35.92M	97.68M	36.02M	38.78M
Sri Lanka Growth	23.22%	-63.22%	171.19%	-7.12%	-30.49%
Bangladesh	60.04M	60.13M	-	48.76M	-
Bangladesh Growth	-0.15%	-	-	-	-
Switzerland	994.86M	1.20B	1.16B	1.17B	829.03M
Switzerland Growth	-17.14%	3.61%	-1.16%	41.42%	46.18%
Total	75.40B	68.18B	55.48B	49.26B	42.57B
Total Growth	10.59%	22.90%	12.62%	15.71%	20.65%

Source: S&P Global Market Intelligence.